PUBLIC COMPANY
save$AMRXAmneal Pharmaceuticals, Inc.
$AMRX18.42+1.49%Bridgewater, NJ, USupdated 11h ago
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall10 co-mentions · 9 sources
- tagSmall Molecule7 co-mentions · 6 sources
- drugCHLORPROMAZINE HYDROCHLORIDE4 co-mentions · 4 sources
- drugtrimethoprim3 co-mentions · 2 sources
- drugMAGNESIUM SULFATE2 co-mentions · 1 sources
- drugmagnesium sulfate Pfizer2 co-mentions · 1 sources
- drugmagnesium sulfate Fresenius2 co-mentions · 1 sources
- drugmagnesium2 co-mentions · 1 sources
pipeline
36
marketed
29
phase 3
1
catalysts ytd
40
approvals ytd
28
recalls ytd
5
Pipeline(36)
view full pipeline →pipeline depth36 products
1Preclinical2Phase 21Phase 329Marketed3Unknown
Marketed
BREXPIPRAZOLE
5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 1A
MarketedBoruzu
Mantle Cell Lymphoma
MarketedCALCIUM CHLORIDE 10%
cardiac arrest
MarketedCUPRIC CHLORIDE
MarketedCrexont
Parkinson's Disease
MarketedDEFLAZACORT
Glucocorticoid receptor
MarketedDOXYCYCLINE HYCLATE
Bacterial 70S ribosomeInterstitial collagenase
MarketedELTROMBOPAG OLAMINE
Thrombopoietin receptor
MarketedEPIRUBICIN HYDROCHLORIDE
Breast Cancer
MarketedFenoglide
Hypercholesterolemia
MarketedIOHEXOL
MarketedLABETALOL HYDROCHLORIDE
Adrenergic receptor
Upcoming
Recent(90d)
earnings (2)
Active trials
- phase1SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females
- phase1A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 4, 26tax coverPatel Chirag K. · President & Co-CEO37,825 sh
- Mar 4, 26tax coverPatel Chintu · Co-CEO28,983 sh
- Mar 4, 26tax coverKonidaris Tasos · Executive Vice President & CFO22,035 sh
- Mar 4, 26tax coverBOYER ANDREW S · Executive Vice President19,136 sh
- Mar 4, 26tax coverShah Nikita · Executive Vice President17,976 sh
- Mar 4, 26tax coverDaly Jason B. · EVP, Chief Legal Officer15,580 sh
🐶 Hiring Signal
next earnings Oct 29, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that